Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaAll Plans · Coverage · Medical Policy · OphthalmologyLow impact

Anecortave Acetate (Retaane) (CPB 0706, reviewed 2025-11-24)

Effective date
Not stated in the notice
Identified
Aug 17, 2026

Summary

Historical Aetna clinical policy bulletin (CPB 0706, reviewed 2025-11-24, first detected by PolicyChanges 2026-08-17) that states Aetna considers anecortave acetate (Retaane) experimental, investigational or unproven for age-related macular degeneration, glaucoma and retinoblastoma because its effectiveness has not been established. No effective date is stated, so check current applicability before acting. Billing teams that bill these diagnoses should confirm the drug is not on their charge lists and route any claims for it to the provider for review.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 3 steps
01No effective date is stated in the source, and this is older material newly discovered, so check current applicability on the Aetna site before acting.
02Billing team: search charge entry and the drug list for anecortave acetate (Retaane) and, if it appears on any claim for the listed ICD-10 diagnoses (retinoblastoma C69.20 to C69.22, age-related macular degeneration H35.3110 to H35.3293, glaucoma H40.001 to H42), send the claim to the provider for review before submission.
03Providers: confirm the drug is documented as experimental for these indications before it is ordered for an Aetna patient.

Codes mentioned

C69.20C69.22H35.3110H35.3293H40.001H42

Original notice

Anecortave Acetate (Retaane) (CPB 0706, reviewed 2025-11-24)
aetna.com · Always check the source before changing claims.
View original ↗

Related changes

See all Aetna changes →
Brachytherapy (CPB 0371, reviewed 2026-05-20)MediumNo effective date · Medical PolicyExtended Ophthalmoscopy (CPB 0767, reviewed 2025-12-02)MediumNo effective date · Medical PolicyAnterior Segment Scanning Computerized Ophthalmic Diagnostic Imaging (CPB 0749, reviewed 2026-10-21)MediumNo effective date · RadiologyTranspupillary Thermal Therapy (CPB 0490, reviewed 2026-10-05)MediumNo effective date · Medical PolicyBrowse every Aetna change in the policy list

Related policy hubs

Aetna policiesOphthalmologyCode C69.20Code C69.22Code H35.3110Code H35.3293Code H40.001Code H42

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account